PCA assay.
Tissue factor (TF) is a transmembrane receptor that serves as the major cofactor for factor Vlla-catalyzed proteolytic activation of factors IX and X. In response to bacterial lipopolysaccharide (LPS), monocytes transcribe, synthesize, and express TF on their surface, thereby conveying to activated monocytes the ability to initiate the blood coagulation protease cascades. Agents that elevate cellular cyclic AMP (CAMP) inhibit the functional expression of TF by LPSstimulated monocytes. In this study, we investigated the mechanism of this suppression. Northern blot analysis of total RNA from LPS-stimulated monocytes showed a concentration-dependent decrease in TF messenger RNA (mRNA) levels in response to dibutyryl-CAMP (dBt-CAMP). TF mRNA and procoagulant activity were inhibited as early N EXPOSURE TO a variety of stimuli, eg, bacterial 0 endotoxin, immune complexes, proteolytic complement fragments, antigen-driven T-helper cells, and specific lymphokines, blood monocytes and tissue macrophages synthesize and express tissue factor (TF), an integral membrane glycoprotein that, assembled with factor VII/VIIa, initiates the coagulation protease cascades.'" TF is the cofactor for factor VIIa-catalyzed proteolytic activation of factors IX and X.6*7 Circulating activated monocytes are thus able to activate blood coagulation and to induce pericellular fibrin.' In view of this ability to express surface TF and to generate thrombin, mononuclear phagocytes have been implicated in the activation of intravascular and extravascular coagulation associated with malignancy: endotoxemia,l0.'l and immunologic diseases." TF expression after exposure to lipopolysaccharide (LPS) appears to be under transcriptional control in human peripheral monocytes.13 It has been shown that in the human monocytic leukemia cell line THP-1, LPS-induced accumulation of TF messenger RNA (mRNA) is regulated by both transcriptional and posttranscriptional control mechanisms. l4 Transcriptional regulation in response to LPS has been localized to a 56-bp LPS response element (LRE) in the 5' flank of the TF gene.15 Cyclic AMP (CAMP) analogs and pharmacologic agents that elevate intracellular cAMP concentrations, such as pentoxifylline,16 dipyridamole,17,18 iloprost, l9 and iso-butyl-methyl-xanthine (IBMX)?' apparently have an inhibitory effect on the expression of functional TF procoagulant activity by LPS-stimulated monocytes. cAMP is a second messenger reported to regulate the biosynthesis of certain monocyte proteins at the mRNA level; increased cytosolic cAMP levels inhibit LPS-stimulated expression of the tumor necrosis factor a (TNFa) gene at the transcriptional leve1,21,22 whereas the JE gene is inhibited at a posttranscriptional level." The aim of this work was to analyze the effect of cAMP elevation on TF mRNA expression by monocytes in response to LPS.
MATERIALS AND METHODS
RPMI I640 medium, nonessential amino acids, glutamine, penicillin, streptomycin, and pyruvate were obtained from
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as 1 hour after the addition of dBt-CAMP and the inhibition persisted through 4 hours. Suppression of specific mRNA abundance was also observed with agents, including forskolin and iso-butyl-methyl-xanthine (IBMX), that increase cAMP levels by independent mechanisms. Flow immunocytometric analysis confirmed that cell-surface TF protein levels declined in parallel with TF functional activity. The rate of decay of TF mRNA after the arrest of transcription by actinomycin D was not altered by the addition of dBt-CAMP, IBMX, or forskolin, thus excluding effects on TF mRNA stability. We conclude that elevated cAMP levels suppress TF mRNA by reducing the rate of TF gene transcription. 0 1993 by The American Society of Hematology.
J. Bio SA. Fetal calf serum was from GIBCO Laboratories (Grand Island, NY). Endotoxin LPS from Escherichia coli (055-BS), 3-isobutyl-1-methylxanthine (IBMX), forskolin, dibutyryl CAMP (dBt-CAMP), and actinomycin D were from Sigma (St Louis, MO).
Peripheral blood cell suspensions from healthy donors were obtained during routine cytapheresis for the preparation of platelet concentrates from single donors, using either the Dideco or the Cob cell separator. The mononuclear cell fraction was prepared by the Ficoll-Hypaque gradient technique16; monocytes were further purified (60% to 93%) by adheren~e.2~ These cells were incubated at 37°C under 5% CO2 for 1 to 4 hours, with or without 1 pg/mL LPS or with additional reagents. At the end of incubation, the medium was discarded and the cells were washed and stored for less than 1 week at -80°C until procoagulant activity (PCA) measurement or RNA extraction.
Immediately before the PCA assay, the cells were lysed with 16 mmol/L octyl-6-D-glycopyranoside at 37°C for 10 minutes and diluted threefold.24 PCA was quantified by a one-step plasma recalcification time assay.'6.24 Clotting times were analysed in comparison to serial dilutions of a standard TF preparation (Thrombomat; BioMerieux, Craponne, France) and PCA was expressed as milliunits of TF per lo6 monocytes. To determine the proportion of PCA that was TF-initiated, residual PCA was measured in some experiments after incubating the cell lysate with a pool of neutralizing TF monoclonal antibodies (MoAbs) (TF8-5G9, TF8-6B4, and TF9-9C3)25 at 10 pg/mL for 10 minutes.
Total RNA was extracted by means of the guanidinium-thiocyanate/cesium chloride method according to Maniatis et a126 with some modifications; the homog-
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OLLlVlER ET AL enization buffer was 5 mol/L guanidinium thiocyanate, 0.05 mol/L Tris-HCI (pH 7.5), 0.01 mol/L EDTA, 5% 0-mercaptoethanol, and 1% sodium lauryl sarcosinate. Frozen monolayers of monocytes were thawed directly in homogenization buffer at room temperature. The cell lysate was layered onto a cushion of 5.7 mol/L CsCI-0.005 mol/ L EDTA (pH 8) and centrifuged at 20°C for 2 hours at 488,OOOg on a TLA 100.3 rotor (Beckman, Gagny, France). The RNA pellet was suspended in I O mmol/L Tris, 1 mmol/L EDTA, 1% sarcosyl, and precipitated with ethanol after the addition of 0.1 mol/L sodium acetate. The pellet was rinsed with 70% ethanol, dried under nitrogen, and dissolved in a small volume of water. The RNA concentration was derived from the optical density at 260 nm. The OD260/OD280 ratio was always greater than 1.6.
Five micrograms of total RNA was fractionated on a 1% agarose/ 1.1 mol/L formaldehyde gel and transfered by vacuum (Vacu-Aid; Cera-Labo, Aubervilliers, France) onto nitrocellulose Hybond C-extra membranes (Amersham, Les Ulis, France) in 20X SSC,', washed in 5X SSC buffer, air-dried. and baked for 2 hours at 80°C. The filters were prehybridized for 8 hours at 42°C in 5X SSC buffer, 50% formamide, 1% sodium dodecyl sulfate (SDS), 0.5% skimmed milk, and 0.5 mg/mL denatured salmon-sperm DNA. The filters were hybridized with the TF or &actin cDNA probes labeled with [a3*P]dCTP for 24 hours at 42°C in a shaking water bath and then washed in 2X SSC, 0.1% SDS for 30 minutes at room temperature, followed by one or two washes in 0. I X SSC, 0.1% SDS at 65°C. They were then exposed to X-OMAT Kodak films (Sigma) with an intensifying screen at -80°C. The results were compared with those for a &actin mRNA derived from a stable gene constitutively expressed in monocytes and unaltered by CAMP.
Preparation of probes. cDNA probes were labeled with [ ( u~~P ]~C T P (3,000 Ci/mmol) by means of random hexamer primer extension using the Multiprime kit (Amersham). The 641-bp TF cDNA probe" was excised from plasmid pUC8 with EcoRI. The 822-bp 0-actin cDNA probe was excised from plasmid pGEM3 with EcoRI and HindIII; this latter probe is a murine probe that crossreacts with human actin mRNA and was kindly provided by Dr Alvarado (Institut Pasteur, Paris, France). The G3PDH probe was purchased from Clontech (Palo Alto, CA). Even loading of RNA was assessed by using one of the "house keeping" genes, @-actin or G3PDH.
The effect of dBt-CAMP on TF mRNA stability was examined by inhibiting mRNA transcription with actinomycin D. After incubating the cells with LPS, and with or without dBt-CAMP for 2 hours, actinomycin D was added at a final concentration of IO &mL and the disappearance of TF mRNA was analyzed by Northern blotting. The autoradiograms were scanned by laser densitometry with a Sebia Preference R apparatus (Sebia, Issy Pes Moulineaux, France) for the relative levels of mRNA in treated and untreated monocytes. The effect of dBt-CAMP, forskolin, and IBMX on TF mRNA stability was also examined by adding these agents just after the arrest of transcription by actinomycin D.
After incubation with or without LPS and inhibitors, the cells were washed twice in cold phosphate-buffered saline (PBS) and fixed by the addition of cold 1% paraformaldehyde in PBS. They were then washed three times and incubated for 30 minutes at 4°C with either an IgG antihuman TF murine MoAb (MoAb4; Corvas, San Diego, CA) or an IgGl control isotype (Becton Dickinson, Mountain View, CA). After further washing, the cells were stained with the F(ab)z fraction of a fluorescein isothyocyanate (FITC)-labeled goat antimouse IgG (Caltag Laboratories, San Francisco, CA) for 30 minutes at 4°C and then washed and incubated with a phycoerythrin-conjugated anti-CD 14 mouse MoAb (Immunotech, Luminy, France). The stained cells were washed and fixed in 1% paraformaldehyde buffer. Flow cytometric analysis was per-Transcript stability analysis.
Flow cytometric analysis.
formed using a FACScan analyzer (Becton Dickinson) equipped with a 15-mW, 488-nm argon-ion laser. Red and green fluorescence emission was recorded at 580 nm and 530 nm, respectively. A total of 5,000 events per sample were analyzed.
Gating of monocytes was performed using anti-CD14+ cells. Median channel fluorescence was determined for each sample using a log scale. Log channel fluorescence units were converted to linear channel fluorescence units to facilitate comparison of samples. Nonspecific fluorescence, determined using the negative control antibody (IgG1 control isotype), did not differ by more than 10% between samples. Specific relative linear fluorescence was obtained by subtracting background linear fluorescence produced by the negative control.
RESULTS
The effects of CAMP on TF expression by LPS-stimulated monocytes were initially investigated using dBt-CAMP, a membrane-permeable analogue of this cyclic nucleotide. TF transcripts were not detectable in unstimulated monocytes ( Fig 1A) . In contrast, exposure to LPS at 1 pdmL in complete medium for 4 hours was associated with marked accumulation of TF mRNA. The addition of increasing concentrations (from 25 to 500 pmol/L) of dBt-CAMP to monocytes at the time of LPS stimulation was associated with a concentration-dependent decrease in both 3. I-and 2.3-kb T F mRNA content ( Fig 1A and B ). No changes in &actin mRNA content were observed in control or drug-treated cells. pactin mRNA was thus used as an internal control. Paralleling the effect on TF mRNA, dBt-CAMP had a concentrationdependent inhibitory effect on LPS-induced monocyte PCA ( Fig IC) . The concentrations of dBt-CAMP necessary to suppress LPS-induced PCA and TF mRNA by 50% were 100 and 25 pmol/L, respectively. PCA was identified as T F as more than 99% was inhibited by a cocktail of MoAbs to human TF. In a typical experiment, incubation of a lysate of LPS-activated monocytes with antibodies to TF prolonged the clotting time from 38.8 seconds (3,430 mU/106 monocytes) to 250.4 seconds (<30 mU/106 monocytes); the residual PCA after dBt-CAMP treatment was also completely inhibited.
Similarly, levels of TF mRNA from monocytes exposed to LPS (1 pg/mL) with or without dBt-CAMP (100 pmol/L) pretreatment for various times (0 to 4 hours) were compared (Fig 2) . After LPS stimulation, TF mRNA levels increased gradually from 0 to 4 hours (Fig 2A and B) . When dBt-CAMP was added, the appearance of TF mRNA was inhibited as early as the first hour and the effect continued at 2 and 4 hours. Actin mRNA levels were not altered in these cells at any time after challenge with LPS and dBt-CAMP (Fig 2A) . The PCA of similarly treated monocytes was determined concomitantly. Figure 2C illustrates that PCA increased gradually from 0 to 4 hours after stimulation with LPS, whereas there was a 50% inhibition of PCA at each time point after the addition of dBt-CAMP.
As shown in Fig 3A and B , the level of LPS-induced TF mRNA was also reduced by 100 pmol/L forskolin or IBMX pretreatment, with a 60% to 80% decrease at 4 hours. A 50% decrease in PCA was induced by all three drugs at this concentration ( Fig 3C) .
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From Flow immunocytometric analysis was used to determine whether dBt-cAMP reduced the amount of TF protein expressed on the cell surface in parallel with T F functional activity. The addition of increasing dBt-cAMP concentrations (25 to 500 pmol/L) was associated with a concentration-dependent decrease in the fluorescence level of LPS-induced TF-positive cells. The PCA and immune fluorescence values measured in the same experiment were correlated (slope = 42.4, r = .977, P < .001). The fluorescence of LPS-exposed monocytes was also inhibited by the presence of 100 pmoll L forskolin or IBMX. These agents reduced the specific relative fluorescence of LPS-exposed monocytes from 239 to 83, 82, and 93 with dBt-cAMP, forskolin, and IBMX, respectively (Fig 4) .
The effect of dBt-cAMP treatment on TF mRNA stability was examined by inhibiting mRNA transcription with actinomycin D in intact cells. Two types of experiments were performed (Fig 5) . After incubating the cells with L E , with or without 50 pmol/L dBt-cAMP pretreatment for 2 hours, actinomycin D was added at a final concentration of 10 pgj mL, and the disappearance of T F mRNA with time was analyzed by Northern blot hybridization with scanning densitometry. As shown in Fig 5A and B , the yield of mature 2.3kb T F mRNA decreased similarly in the presence and absence of dBt-cAMP. To further analyze the effect of dBt-cAMP on T F mRNA stability, cells were incubated with LPS for 2 hours; actinomycin D and dBt-cAMP were then added and the disappearance of TF mRNA with time was analyzed. As shown in Fig 5, the addition of the cAMP analogue after the arrest of transcription did not modify the rate of TF mRNA disappearance. Similarly, TF mRNA stability was not affected by the addition of either 100 pmol/L IBMX or 100 pmol/L forskolin after the arrest of transcription by actinomycin D (Fig 6) .
DISCUSSION
The results of this study indicate that elevated cellular levels of the second messenger cAMP diminish the accumulation Similar results were obtained with forskolin and IBMX, which, by independent mechanisms, increase intracellular cAMP levels. Forskolin directly activates the catalytic s u b units of adenylate cyclase, whereas IBMX inhibits phosphodiesterase activity. At 100 pmol/L, both agents reduced PCA by 50% and inhibited TF mRNA more strongly.
Quantitative flow immunocytometric analysis with specific MoAbs confirmed that TF protein expression on the cell surface was reduced by the cAMP analog and intracellular CAMP-increasing agents in parallel to PCA activity. These results confirm the positive correlation reported by Luther et aI2' between functional TF-mediated PCA measured in clotting tests and TF expression measured immunologically by means of flow cytometric analysis. This is important, because the existence of T F pathway inhibitor (TFPI) mRNA29 in both resting and LPS-stimulated monocytes suggests that it could play a role in the decrease in TF activity. Moreover, membrane alterations that affect the cofactor activity of T F may be a means of regulating the initiation of the coagulation protease cascade.w Tannenbaum and Hamilton2' found that cAMP affected specific mRNA accumulation by more than one mechanism. dBt-cAMP suppresses LPS-induced transcriptional activation of the TNFa gene:l*22 whereas its effect on JE mRNA accumulation appears to involve a posttranscriptional mechanism. In the present study, the stability of LPSinduced TF mRNA was not affected by dBt-cAMP. TF mRNA stability was similar whether cAMP levels were increased by the dBt-cAMP before or after transcriptional arrest with actinomycin D. Similarly, TF mRNA stability was not affected by the addition of either IBMX or forskolin. A posttranscriptional mechanism, such as accelerated destruction of TF mRNA by nucleases, is thus unlikely to be involved in the decrease in TF mRNA levels. This tends to reinforce the similarity between TF and TNFa mRNA regulation, as TNFa mRNA stability is unaffected by CAMP?' However, although cAMP appears to modulate TF mRNA expression at the transchp tional level, our results suggest that posttranscriptional effects may also occur. With 25 pmol/L dBt-cAMP, the production of TF mRNA was strongly suppressed (-go%), whereas PCA and cell-surface TF expression were less markedly reduced. The PCA assay is far more sensitive than Northem blotting and this may explain in part some of the differences in the concentrations of dBt-cAMP that were required for a 50% inhibition of PCA as contrasted to TF mRNA levels. However, the relationship between mRNA accumulation and protein synthesis may be complex; the greater decrease in mRNA than in TF protein could be related to a relative increase in translational efficiency or a prolonged TF protein half-life on the cell surface. No linear relationship between the decay of TF mRNA and that of TF protein was found by Gregory et all3 or Brand et all4 on the basis of PCA analysis. Studies of TF biosynthesis have concluded that regulation occurs via modifications of both the rate of transcription and the mRNA half-life.I4 The existence of posttranscriptional regulation in this system is supported by the presence of several AU-rich motifs in the 3' untranslated region of TF mRNA?6 Recent work hasdrawn attention to such sequences as elements not only capable of directing mRNA degradation but also ofsuppressing tran~lation.~' Thus, an additional effect of elevated cAMP levels on TF translation cannot be completely ruled out. For personal use only. on October 23, 2017. by guest www.bloodjournal.org From TF synthesis, the involvement of protein kinase C has been ~u g g e s t e d .~*~~~ Crosstalk between the cAMP and protein kinase C pathways has been described in a variety of cells," and this could modulate the transduction pathway and thereby prevent activation of the relevant transcription regulation factors. Other transduction pathways, such as protein tyrosine kinase phosphorylation, have been implicated in the macrophage response to L E . " The involvement of such a pathway might explain why dBt-cAMP did not completely inhibit PCA, even at concentrations as high as 500 pmol/L.
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In mammalian cells, cAMP has also been shown to promote the transcription of a number of gene^.^.^' Transcrip tional activation ofgenes such as &pol requires the presence of a CAMP-responsive element (CRE), which consists of a central nucleotide octamer with diad symmetry within the TGACGTCA sequence.3* The functional effects are thought to be modulated by phosphorylation of CREB.'*39 A nucleotide sequence similar to a CRE is present in intron l of the TF gene,40 but its relevance remains to be determined. 
